A-A-0053406(DM)
28 March 1988
INTERIM COMMERCIAL ITEM DESCRIPTION
POTASSIUM ACETATE INJECTION, USP
The General Services Administration has authorized the use of this Interim Commercial Item Description which was developed by the Defense Personnel Support Center, Directorate of Medical Materiel, DPSC-RST, 2800 South 20th Street, Philadelphia, PA 19101, based upon currently available technical information.
Salient characteristics:
Shall be Potassium Acetate Injection, USP.
Shall be in accordance with the requirements of the USP.
Shall contain 40 mEq of Potassium, as Potassium Acetate, within the applicable assay limits.
All ingredients shall be of pharmaceutical grade.
Workmanship. The injection shall be free from defects which detract from its appearance or impair its serviceability.
Unit. Package (PG). Shall be supplied 20 ml in a commercially available vial. One package containing 25 vials, as specified, constitutes one unit.
Contractor certification. The contractor shall certify that the product offered meets the salient characteristics of this description and conforms to the producers’ own drawings, specifications, standards, and quality assurance practices. The Government reserves the right to require proof of such conformance prior to first delivery and thereafter as may be otherwise provided for under the provisions of the contract.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business